Wang et al. demonstrated that SH3GL3 acts as a TSG by inhibiting the cell cycle at the G0/G1 phase and inducing apoptosis in lung cancer cells; as such, it was indicated as a biomarker for the diagnosis and prognosis of lung cancer [19]. Here, SH3GL3 is linked to lung carcinoma.